Cerebras Systems Jumps as OpenAI Partnership Reassurance Lifts Sentiment

Cerebras Systems (CBRS) is up 7.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is renewed confidence in Cerebras’ OpenAI relationship after Sam Altman described Cerebras as a close partner and said the two have a deep engagement around speed. The rebound also appears to be helped by a string of recent customer and infrastructure announcements, which may have encouraged dip-buying after last week’s sharp selloff.

Details:

Sam Altman posted on October 3 that Cerebras is a close partner of OpenAI, easing concern that Cerebras was being pushed aside in key inference workloads.

Cerebras announced a multi-year agreement on September 29 with General Compute to deploy its ultrafast inference systems at scale, with availability planned for the first quarter of 2027.

On September 28, Cerebras and Gimlet Labs announced a collaboration aimed at delivering ultrafast AI inference, including planned speeds of up to 3,000 tokens per second and a first datacenter coming online later this year.

Analyst sentiment also stayed constructive, with fresh Buy ratings and price targets listed on October 5, which likely reinforced the recovery in shares.

Sources:

Cerebras, X, Google Finance, SEC

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CBRS Insider Trading Activity

$CBRS insiders have traded $CBRS stock on the open market 333 times in the past 6 months. Of those trades, 0 have been purchases and 333 have been sales.

Here’s a breakdown of recent trading of $CBRS stock by insiders over the last 6 months:

SEAN LIE (Chief Technology Officer) has made 0 purchases and 63 sales selling 931,290 shares for an estimated $193,791,957.
DHIRAJ MALLICK (Chief Operating Officer) has made 0 purchases and 103 sales selling 514,334 shares for an estimated $103,558,157.
ANDREW D. FELDMAN (CEO, President) has made 0 purchases and 67 sales selling 319,634 shares for an estimated $64,252,741.
STEVEN VASSALLO has made 0 purchases and 8 sales selling 100,000 shares for an estimated $21,424,236.
ERIC VISHRIA has made 0 purchases and 6 sales selling 68,268 shares for an estimated $15,685,957.
ROBERT PATRICK JR. KOMIN (Chief Financial Officer) has made 0 purchases and 16 sales selling 32,500 shares for an estimated $6,614,881.
YAGNESH PATEL (Chief Accounting Officer) has made 0 purchases and 70 sales selling 15,973 shares for an estimated $3,025,898.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive CBRS Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CBRS Hedge Fund Activity

We have seen 387 institutional investors add shares of $CBRS stock to their portfolio, and 0 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ECLIPSE OPERATIONS, LLC added 11,446,270 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,529,625,670
FMR LLC added 8,435,095 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,864,155,995
COATUE MANAGEMENT LLC added 7,011,028 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,549,437,188
CAPITAL WORLD INVESTORS added 3,894,458 shares (+inf%) to their portfolio in Q2 2026, for an estimated $860,675,218
MORGAN STANLEY added 3,224,209 shares (+inf%) to their portfolio in Q2 2026, for an estimated $712,550,189
ATREIDES MANAGEMENT, LP added 3,110,086 shares (+inf%) to their portfolio in Q2 2026, for an estimated $687,329,006
JPMORGAN CHASE & CO added 3,100,806 shares (+inf%) to their portfolio in Q2 2026, for an estimated $685,278,126

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CBRS Analyst Ratings

Wall Street analysts have issued reports on $CBRS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 06/08/2026

To track analyst ratings and price targets for $CBRS, check out Quiver Quantitative's $CBRS forecast page.

$CBRS Price Targets

Multiple analysts have issued price targets for $CBRS recently. We have seen 11 analysts offer price targets for $CBRS in the last 6 months, with a median target of $300.0.

Here are some recent targets:

Paul Meeks from Freedom Capital Markets set a target price of $209.0 on 06/30/2026
N. Quinn Bolton from Needham set a target price of $300.0 on 06/24/2026
Matt Bryson from Wedbush set a target price of $280.0 on 06/24/2026
Joseph Moore from Morgan Stanley set a target price of $273.0 on 06/24/2026
Kevin Cassidy from Rosenblatt set a target price of $300.0 on 06/24/2026
Timothy Arcuri from UBS set a target price of $320.0 on 06/24/2026
Richard Shannon from Craig-Hallum set a target price of $325.0 on 06/09/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.